You are reading the article Revealed: The World’s 10 Highest updated in March 2024 on the website Bellydancehcm.com. We hope that the information we have shared is helpful to you. If you find the content interesting and meaningful, please share it with your friends and continue to follow and support us for the latest updates. Suggested April 2024 Revealed: The World’s 10 HighestThese top-earning celebrities, musicians and creators made more than $1.3 billion last year.
These top-earning celebrities, musicians and creators made more than $1.3 billion last year.
All figures in this article are in USD.
After releasing her tenth studio album, Midnights, in October 2023, Taylor Swift became the first artist in history to claim the top ten spots on the Billboard Hot 100 song list. A month later, 14 million loyal fans tried to buy tickets to the 12- time Grammy winner’s 2023 Eras Tour, overwhelming Ticketmaster and prompting a massive backlash against the ticket site, with the Department of Justice reportedly opening an antitrust investigation.
Despite the success of Midnights and the anticipation for Eras (which hints at an even better 2023), the pop icon scored most of her $92 million in earnings from music she’d released in years past. The 33-year-old’s back catalog made up an estimated 70% of her pay, including profits from streaming and album sales. (Universal Music Group, which gets 3% of its revenue from Swift, sold $50 million worth of physical albums in 2023, per a JPMorgan analyst report). It was enough to place the musician at No. 9 among the top 10 earning entertainers; it’s the sixth time she’s made the cut—and she ranked No. 1 in 2023.
As good as Swift’s year was, it was even better for several aging rock stars. The Rolling Stones banked $98 million from belting out their hits and celebrating 60 years together on their European Sixty tour last year.
Genesis and Sting did even better. Although not at the eye-popping valuations seen in Bob Dylan or Bruce Springsteen’s landmark $500 million deals—both sold their life’s work for $300 million apiece, showing that investors still see popular music with deep libraries as a safe bet. Genesis was deemed that valuable despite the fact that the deal excludes the work of onetime member Peter Gabriel. Genesis even beat out the former Police front man (whom younger fans may know better from his cameo in Hulu’s Only Murders In The Building, alongside Selena Gomez), thanks to an estimated $27 million infusion from touring—enough to earn the top spot on the list for the first time ever.
There are plenty of other signs that the entertainment industry likes sure things. Thirty-four years after The Simpsons first aired, two creators of America’s favorite yellow family debut at No. 5, thanks to a 2023 streaming deal that migrated all 30 seasons to Disney+ and put a previously unreported $105 million in their pockets annually. And James Cameron, the director you “never bet against,” is back in the top 10 after a dozen years away. His Avatar sequel, The Way of Water, and its blue-skinned beings have breathed some much-needed life back into the box office. Still in theaters, it has grossed over $2.1 billion to date since its December release.
Box-office stars have had a tougher go of it. The only ones in the top 10 are Tyler Perry and Brad Pitt, both of who made most of their income off-screen. Pitt, who last appeared among the top 10 in 2009, sold a majority stake in his production company, Plan B, to European media conglomerate Mediawan in a December deal that valued the business at $300 million. His roles in Bullet Train, Babylon and The Lost City accounted for an estimated third of his income.
The only true newcomer to this year’s list: Puerto Rican rapper Bad Bunny, who sold $400 million worth of tickets to his two tours—the first in the spring in the U.S., the second in the fall across the States plus Latin America—according to concert tracker Pollstar. His second tour, dubbed The World’s Hottest, was an expensive affair. It took 35 to 40 trucks to cart gear and crew from venue to venue across the U.S. and then used three planes—including a 747 cargo jet—to transport everything for the Latin American leg, according to sources with knowledge of the tour. That kind of spectacle may have helped sales but meant fewer dollars in the star’s pocket. Including endorsements, Bad Bunny earned $88 million.
Altogether this year’s biggest earners hauled in $1.35 billion, half as much as last year’s top 10 that included Jay-Z, Kanye “Ye” West and Bruce Springsteen. Only two appeared on both lists: Tyler Perry and South Park creators Trey Parker and Matt Stone.1. Genesis • $230 million
The pioneers of progressive rock topped 2023 with a $300 million music rights sale to Concord Music Group in September. The deal comprised publishing rights and a selection of recorded music income streams from the group, as well as solo income streams from Phil Collins (including hit song “In The Air Tonight”) and bandmates Tony Banks and Mike Rutherford. Touring and recorded music royalties rounded out their income.2. Sting • $210 million
Sting. Image: Getty
The 17-time Grammy winner and former Police frontman—known for hits including “Every Breath You Take” and “Roxanne”—pocketed $300 million before fees by selling his entire musical output, both solo and with The Police, to Universal Music Group in February. “It’s a good catalog,” says one longtime industry attorney on the British singer’s work. “Wouldn’t mind owning it.”3. Tyler Perry • $175 million
Tyler Perry. Image: Getty
Just call multi-hyphenate Perry a modern Renaissance man. The actor-director-writer-studio mogul had another lucrative year thanks to simultaneous income streams from film, his BET TV shows and the sprawling production backlot he outright owns in Atlanta. In his second year among Forbes’ top 10 highest-paid entertainers, Perry is the list’s sole billionaire with an estimated $1 billion fortune.4. Trey Parker & Matt Stone • $160 million
South Park writers/creators Matt Stone (L) and Trey Parker (R). Image: Getty
The devilish duo behind South Park had another banner year, thanks to earnings from a legacy HBO Max deal and Book of Mormon, their comedic musical (and skewering) of the Church of Jesus Christ of Latter-Day Saints. The majority comes from their Paramount deal, signed in 2023 and guaranteeing the pair $935 million over six years.5. James L. Brooks & Matt Groening • $105 million
James L. Brooks & Matt Groening. Image: Getty
America’s favorite yellow cartoon family, The Simpsons, migrated all 30 seasons to Disney+ from FX in an April 2023 streaming deal made after Disney’s previous acquisition of Fox for some $52 billion. Series co-creators Brooks and Groening aren’t having a cow, man, having earned a previously unreported $105 million annually after fees, according to sources familiar with the deal.6. Brad Pitt • $100 million
Brad Pitt. Image: Getty
Pitt’s majority sale of his Plan B production company in December earned the actor an estimated $113 million after fees. The deal also had Hollywood chattering. “It’s definitely become a brand,” says one lawyer, adding that Plan B in addition to producing Oscar winners Moonlight, 12 Years A Slave and Martin Scorsese’s The Departed, likely owns back ends and has a development slate that would increase its value. Others weren’t sold. “It doesn’t really have assets,” says a second attorney, pointing out that the company simply produces projects, rather than owning them. Pitt earned an additional estimated $30 million from roles in Bullet Train, Babylon and The Lost City.7. Rolling Stones • $98 million
The Rolling Stones. Image: Getty
If Mick Jagger, Keith Richards and company can’t get (no) satisfaction from a $136 million grossing tour and record royalties, then perhaps they should paint their coffers black. The OG British rockers pocketed over $8.5 million per night on a 15-city tour across Europe last summer, according to concert tracker Pollstar.8. James Cameron • $95 million
Film Director James Cameron. Image: Getty
His wallet will go on: The smash success of Avatar: The Way of Water made Cameron the director of three of the highest-grossing movies of all time, alongside the first Avatar (2009) and Titanic (1997). His second outing to Pandora netted him at least $95 million, according to industry insiders, in a deal that’s said to be back-end-heavy with bonuses for crossing certain box office thresholds.9. Taylor Swift • $92 million
Taylor Swift. Image: Getty10. Bad Bunny • $88 million
Bad Bunny. Image: Getty
The Puerto Rican rapper, best known for combining reggaeton (a mix of Caribbean reggae and mainland rap) with Latin trap (a hip-hop subgenre with roots in the southern U.S.) charmed millions around the world as he flew on a palm tree on tour, appeared alongside Brad Pitt in Bullet Train and challenged machismo with genderfluid style. The lion’s share of his income came from two tours: El Último Tour Del Mundo, performed in arenas, and The World’s Hottest Tour, his first time playing in the biggest possible stadiums. Endorsements with the likes of Corona, Cheetos and Adidas were icing on the cake.
Look back on the week that was with hand-picked articles from Australia and around the world. Sign up to the Forbes Australia newsletter here.METHODOLOGY
Figures represent 2023 pretax earnings, minus fees for representation—managers, lawyers, agents—and/or business operating costs. Sources include data from Nielsen BookScan, Luminate, Pollstar, IMDBPro and Variety Insight, as well as interviews with agents, lawyers, managers, executives and industry experts.
You're reading Revealed: The World’s 10 Highest
Hundreds of amateur balloonists will send their creations into near space in April. You can join, too. To take part in the world’s largest space-balloon event, called the Global Space Balloon Challenge, sign up at chúng tôi then tie a payload to a high-altitude balloon and launch it between April 10 and 27. Sixty teams from six continents flew balloons during last year’s event, according to organizers. This year, more than 100 teams have already signed up.
High-altitude balloons are big, unmanned balloons like the ones meteorologists use to gather data from the stratosphere for weather predictions. They’re about five feet in diameter, when inflated. They can reach heights of more than 100,000 feet—higher than a passenger plane—yet cost less than $1,000 to make. They can also carry science experiments—the Global Space Balloon Challenge includes a prize for best experiment. They take awesome pictures. You can see some of our favorites from last year’s challenge in the gallery below.
Last year’s participants included ballooners of varying levels of ability. There were parent-kid teams, experienced adult balloon enthusiasts, and undergraduate and graduate engineering students. For those who have never flown a high-altitude balloon, the Global Space Balloon Challenge site has starter tutorials and forums for teams to ask questions. The project also has a couple of programs for beginners, including a mentoring program and a program where a beginner team can design an experiment to fly on an experienced team’s balloon.
P.S. While researching amateur ballooning, I learned a little news you can use. The U.S. National Weather Service sends hundreds of high-altitude balloons carrying measuring equipment into near space every day. Eventually those balloons fall back down to Earth. Their equipment is labeled “Harmless Weather Instrument” in case citizens find them. Before learning this, I would have been pretty weirded out to find a giant, deflated balloon labeled “Harmless Weather Instrument,” but now I know it’s not just aliens trying to trick me. If you want to be nice, you can mail the instrument back to the Weather Service inside its own postage-paid mailbag.
Check out photos below from the 2014 Global Space Balloon Challenge
Eye on Earth
No need to go up in a spaceship. This gorgeous photo was taken from a balloon, launched from the Scottish highlands by a pair of adult brothers.
A team of engineering students from the University of Michigan launched two balloons at once to get this photo, taken over central Michigan.
These Peeps got a ride to near space thanks to high school students in Bishop, California. The marshmallow chicks are guarding a Petri dish of extremophiles, whose reaction to space the students wanted to test. In the background is another balloon the Bishop students launched, carrying a radiation sensor.
Team Alturi prepares its balloon for launch from an airfield in Illinois. When Popular Science noted some team members are a bit smaller than average, Global Space Balloon Challenge organizer Duncan Miller said, “The wind that day almost pulled them off their feet!”
For maximum eyeballs, team RandomRace timed its launch with a bicycling event in St. Petersburg, Russia.
Doing the Math Behind the World’s Biggest War on AIDS BU researchers help shape South Africa’s response to HIV
It was the third blow that spun Busisiwe Sithole’s aching grief into dread. First, her six-month-old son died while Sithole was carrying him on her back. Then doctors told her that her infant had been infected with HIV. Then Sithole learned of her own test results.
“When I found out I was positive,” she says, “it was not an easy thing. I was scared. When I would go to sleep at night, I would see myself dead in my coffin. I would see my older child crying. I was preparing my obituary. Then I talked to a counselor about treatment, and she said, ‘You are not going to die.’”
Seven years later, a healthy-looking Sithole works as a data clerk in Johannesburg’s Helen Joseph Hospital, collecting information for the Health Economics and Epidemiology Research Office (HE2RO), a collaboration of Boston University public health experts and researchers from the University of the Witwatersrand. Just downstairs from her office is the Themba Lethu Clinic, where people come for testing, care, and treatment for HIV and the diseases that go with it. There is, it seems, no end to the patients. In South Africa, one in 10 people is infected with HIV, and HIV/AIDS plays a role in 31 percent of deaths. HIV is the country’s most pressing health problem, and Themba Lethu is its largest HIV/AIDS clinic. With as many as 20,000 patients expected to pass through the doors in 2012, it may be the biggest clinic of its kind in the world.
Sithole says many people she talks to are surprised to learn that she has been HIV-positive for so long, yet shows no signs of ill health. “Just last week a colleague came to me, because she had a family member who didn’t want to take the antiretrovirals because there are stories about them. I told them it’s better to get tested. It’s better to know. Because you can live with it. You can control it. Because I know, I also know that AIDS will not kill me. I know that I am going to see my grandchildren.”
Ian Sanne, a South African infectious disease specialist and a codirector of HE2RO, witnesses the life-restoring powers of antiretrovirals every day. “It’s like a miracle,” he says. “It’s really remarkable what can be done with the drugs.”
It’s also remarkable, Sanne knows, what can be accomplished with data. For the past eight years, he and his colleagues at HE2RO, including Sydney Rosen, a School of Public Health research associate professor of international health, and Matthew Fox (SPH’02,’07), an SPH assistant professor of epidemiology, both at BU’s Center for Global Health & Development (CGHD) and HE2RO codirectors, have been collecting data, running it through algorithms that produce more data, then delivering it to the National Department of Health. HE2RO’s information, empirical evidence of the effectiveness and cost of new and better ways to combat HIV/AIDS, is in some ways as instrumental among South African health policy makers as the new pharmaceuticals are for AIDS patients like Sithole. Decision makers in both the National Department of Health and the Department of Treasury have used the data to frame an HIV program that treats almost two million people.
“There was a significant debate between the Treasury and the Department of Health about how much money should be made available,” says Sanne. “HE2RO, using real data, was able to solve the debate and create a budget with significantly escalating funding over the next five to six years. We managed to persuade the politicians to increase the amount of funding over time to cover three and a half million people.”
Working in a warren of offices in Helen Joseph Hospital, HE2RO’s researchers have embarked on more than 20 studies, most of which focus on better treatment of HIV and tuberculosis. The group’s work, which has mainly been funded by the U.S. Agency for International Development (USAID), has been influential, not only on the design of national health care policy, but also on the international funders of AIDS treatment programs.
“Health economics really drives everything we do, from health effectiveness to costing studies to the new national health policy that the South African government is rolling out,” says John Kuehnle, a health officer at USAID South Africa and contract manager for HE2RO. “BU and HE2RO have been at the front of this movement to use health economics to drive policy. It’s something that USAID and PEPFAR are very thankful for.” PEPFAR (U.S. President’s Emergency Plan for AIDS Relief ) is a government initiative to help save the lives of those with HIV/AIDS worldwide.
“There are a lot of groups that work on research on the HIV epidemic, and typically they approach the problem from the perspective of epidemiology,” says Fox. “Some come from the perspective of economics, or from social science. We combine all of those. By bringing all of that together, we can look at not just what is the best approach for a patient or for a clinic, but we can model the implications for the country. We can find the best strategies and approaches to use on a national scale.”
Despite the vastness of HIV infection in South Africa, the country’s first meaningful treatment programs got off to a painfully late start. Thabo Mbeki, president from 1999 to 2008, publicly questioned the link between HIV and AIDS, and his denial of medical realities delayed the introduction of antiretroviral drugs. Harvard researchers have blamed Mbeki’s failure to act for the deaths of 35,000 babies, as well as for shortening the lives of 330,000 people.
The years of denial were years of frustration for HIV researchers, including Rosen, who began traveling to South Africa in 1999 to examine the implications of HIV/AIDS among workers in the private sector and who lived in Johannesburg from 2003 to 2007. That project introduced her to Sanne, who in 2001 founded a not-for-profit called Right to Care. Since 2004, Right to Care has been funded primarily by PEPFAR, which has spent more than $3.2 billion on programs to prevent and treat AIDS and tuberculosis in South Africa. Right to Care, which has long worked closely with HE2RO, currently provides technical support to 170 treatment sites in five of the nine South African provinces and cofunds treatment for HIV, TB, and cervical cancer for about 150,000 people.
As a base for their joint research on the economics and epidemiology of HIV treatment, Rosen and Sanne founded HE2RO at the University of the Witwatersrand in 2004.Coming out of HIV denialism
Change in South Africa’s approach to HIV came under Mbeki’s successor, Jacob Zuma, when the National Department of Health considered, in late 2009, adopting treatment guidelines then newly recommended by the World Health Organization (WHO). Those included the sweeping measure of treating HIV-positive people when their CD4 count—a measure of the immune system’s strength—is 350 or below, instead of the 200 count that had been the treatment threshold previously.
“When we came out of HIV denialism, we had a very controlled HIV treatment program,” says Sanne. “We needed to scale it. We also needed a switch in treatment regimens, because we learned that the treatment we had been using was quite toxic and needed a lot of monitoring. We learned that there were better treatment regimens for drug resistance.”
In the new government’s National Department of Health, the deputy director general for strategic programs, Yogan Pillay, had learned the same things. And he was eager to learn more.
“Government officials like myself don’t always know the right questions to ask,” says Pillay, who oversees the department’s programs for HIV, AIDS, and TB. “Often, researchers will lead the process by suggesting which questions need to be answered. Is there, for example, resistance building up in patients? If there is, what drugs do they need to switch to? If clinicians are switching regimens, what is the practice implication, and what are the cost implications? Those things have implications from the individual patient to a systemic level with respect to the ordering of drugs.”
For answers, Pillay was introduced in 2009 to Johannesburg-based HE2RO team member Gesine Meyer-Rath, an SPH research assistant professor at the CGHD. Pillay knew that with Right to Care’s health database of 17,000 patients treated at Helen Joseph Hospital, HE2RO had access to one of the biggest treatment cohorts in the country, which meant that it also had the ability to generate authoritative statistics and stable models.
“HE2RO can tell us what’s happening to patients who started treatment in 2004,” says Pillay. “They can predict what is likely to happen to patients in the long term, and what we need to do to prevent patients from moving from first-line treatment to second-line drugs. We need to keep them on first-line drugs as long as possible, because the difference in cost between first-line and second-line drugs is five- or sixfold.”
Cost data are especially important to the government, because unlike countries that depend more heavily on international donor support, South Africa pays for 85 percent of its national HIV program itself, using domestic tax revenues. Meyer-Rath, a health economist and infectious disease modeler who creates the complex mathematical algorithms at the heart of HE2RO’s policy analyses, recalls one of several studies requested by Pillay’s department.
“We were asked to look at the cost of introducing new guidelines for HIV treatment,” she says. “They wanted to pull in more HIV-infected people, raising eligibility for both adults and children, and there wasn’t data out there on what that would mean in terms of the number of eligible patients and the resulting cost. One of the questions we were asked is, what would be the cost implications of starting all children much earlier than was previously the case. There were studies that showed if you wait until children qualify for HIV treatment under the old WHO guidelines, their immune systems are so run down that you lose half of them. But the cost of pediatric HIV treatment hadn’t been analyzed before. So we had to do our own data collection, going into clinics and going through a sample of patient files.”
The problem, says Rosen, is that that kind of data collection is much harder than it sounds.
“In many places in Africa—and probably some in the United States—medical records and data systems are not well-developed,” she says. “Files get lost, and a patient will show up at a clinic and another file is opened with a new number, and there is no way of knowing that those files are for the same person. There is an endless series of those kinds of challenges. It’s very labor-intensive to develop a data set that just says how much something costs.”
“We look at every resource that has been used by a patient,” says Meyer-Rath. “We count every pill, every visit, and we look at the outcomes. In the end we can say that after X years of treatment, the cost of treating kids is this much, and the outcomes are this. We take all the data and we put it all in a gigantic mathematical model and run it for a couple of years and see what changes. Then we go back, collect more data to fill in the gaps, and start the process anew.”
Over the years, the data collected has helped to save many lives, and the job has yielded at least one major revelation: “You can collect all the epidemiological evidence you want,” says Meyer-Rath. “You can study the feasibility and all the other things, but if you don’t talk about cost and cost-effectiveness, you will not get an intervention off the ground. It’s not the first question. The first thing is to prove that it works, but it is almost always the second question.”
With the newborn study, the answer to that second question showed that treating infants sooner rather than later would save 80 percent of the costs of inpatient care—an average of 11 days during the first year of life. It turned out to be a good answer, says Meyer-Rath, because it resulted in a price tag that the government was “happy to pay.”Life-sparing push
In another study, HE2RO looked at the feasibility of using nurses to manage treatment for AIDS patients, a task that had traditionally been performed by doctors.
“One of the big challenges in this country is that we don’t have enough doctors, but we do have nurses,” says Pillay. “But there is a lot of resistance to the idea of using nurses to initiate patients on antiretrovirals, both from doctors and nurses. We needed to know first, is it a good idea from a clinical point of view, can it be done, and third, what are the cost implications? HE2RO helped us in all three areas.”
In the last three years the South African government has doubled the budget for HIV treatment. It has tested 12 million people in a single year, is treating 1.7 million, and is budgeting to treat a total of 3.5 million people in the coming years. The life-sparing push started, says Meyer-Rath, with the willingness of the South African government to change its HIV policy and to act based on evidence, including that from HE2RO’s calculations.
“The thing about HE2RO,” says Pillay, “is they are a group of academics. They’re very rigorous and they are independent of us, so the integrity of the results is not questioned. They strike a good balance between being academic and rigorous and being part of the real world.”
“South Africa now has the largest antiretroviral program for treating AIDS in the world,” says Francois Venter, former president of the Southern African HIV Clinicians Society and an HIV researcher at the University of the Witwatersrand. “For a long time, we didn’t know how to get to that point. HE2RO was instrumental in doing a lot of the costing work, a lot of operational work, and a lot of intellectual work. They were the ones who said, ‘These are the choices you have, and this is what it’s going to cost.’ So for the first time, rather than being a gut-feel program, we have become an evidence-based program. HE2RO can take a lot of credit for that.”
For Fox, Rosen, and other CGHD academics who have split their lives between Boston and Johannesburg, the influence of HE2RO is the fulfillment of an important part of their mission, as well as a validation of the value of multidisciplinary, policy-relevant research. But the biggest fulfillment will come when the tools, team, and skills they have built can deliver the evidence needed for policy decisions even after BU goes home.
“The initial collaboration between Boston University and HE2RO was formative,” says Lawrence Long, a South African health economist and a HE2RO deputy division head. “Over time the role has been to provide expert technical assistance to the local group and to build local capacity. They have done that.”
“It’s not realistic to assume that we can work here indefinitely,” says Rosen. “The funding environment is against that, and countries should have their own capacity to do this work. It’s very important to South Africanize our team. We don’t want to be an American organization in South Africa. We want to be a South African organization that is thriving in collaboration with Boston University.”
Read about HE2RO’s research into better ways to fight TB here.
A version of this article appeared in the summer 2012 issue of Bostonia.
Explore Related Topics:
With services spanning reliable mining machine sharing, compliant global mining infrastructure, and efficiency-boosting smart mining service, Bitdeer Group is a leader in the crypto space.
Bitdeer Group was established by renowned crypto pioneer Jihan Wu, the co-founder of Bitmain and Matrixport, which provides mining-related services to individuals and enterprise clients worldwide. With its headquarters located in Singapore, Bitdeer Group has branches in North America, Europe, and other regions.
Bitdeer Group is committed to becoming the world’s most reliable digital asset mining service provider. It offers three lines of business — Bitdeer, Mining Datacenter, and smart mining service. Bitdeer Group is developing market-oriented strategies and integrating resources for high-quality services and major moves in its global operations.
Mining and acquiring digital currencies are complex processes, but there are ways to obtain newly minted cryptocurrency without contending with technical intricacies. Whether you are a crypto-curious newcomer or a long-time believer, Bitdeer Group’s mining machine sharing, Mining Datacenters, and mining management platform weave together a seamless, easy acquisition strategy for any user around the world. “Bitdeer Group has made arrangements to adapt to developments in the mining sector and changes in the market,” said Matt Kong, CEO of Bitdeer Group.
Moreover, Bitdeer’s service verticals include Cloud Hashrate, Cloud Hosting, and Hashrate Market for retail customers, as well as the Institutional Customer Service. Bitdeer’s cloud service is convenient of its kind for anyone anywhere in the world.
Right now, Bitdeer has hundreds of thousands of mining machines running in Europe and North America, with monthly traffic of over 3 million visitors as an endorsement of long-time clients.
Energy-Efficient Mining Datacenters with a Global Footprint
Mining Datacenter was the first to develop standardized, professional mining facilities and provide cryptocurrency mining services to global partners, drawing from eight years of experience in the field.
This includes site selection, facility design, construction, maintenance, and general one-stop technical support. Its team originates from Bitmain’s former mining department.
So far, more than 30 Mining Datacenters have been constructed for proprietary and client usage, as well as partners located around the world. Bitdeer’s fundamental infrastructure is supported by sophisticated Mining Datacenters located in various parts of the United States and Norway. These facilities can operate at an optimum level under various climate conditions and link up various forms of power supply.
Altogether, Mining Datacenters wield the world’s sizable aggregate mining capacity. Its facility in the USA is one of the largest operations of its kind in North America. Alongside a focus on being fully compliant with regulatory demands, Mining Datacenters are forging a path to 100% renewable energy.
Boosted Efficiency with Smart Mining Service
As an integrated smart mining service of Bitdeer Group, it offers a unified platform for infrastructure oversight and control, giving miners the means to solve problems that they may encounter during their regular operations and achieve the highest efficiency.
This proprietary infrastructure software suite is utilized to regulate the expansive operations involving hardware assets spanning continents. The platform assists miners to prevent and solve problems that may arise during day-to-day operations. It can provide up to a 100% boost in efficiency while eliminating the need for human intervention by 50% for large-scale mining farms.
The platform includes automated monitoring functionalities, batch management features, security capabilities, data-driven analysis, as well as energy and power meter management processes. The platform is calibrated to mesh with all mainstream mining rig models and pools for maximal impact in any context.
Bitdeer Group Is Committed to Becoming the World’s Most Reliable Digital Asset Mining Service Provider
With more than 300 staff spread across facilities around the world, Bitdeer Group is distributed at a global scale, ensuring risk resistance and versatility that enables stable mining 24 hours a day, seven days a week.
That makes it even more crucial to merge diverse cloud services with its infrastructural backbone and intelligent management and maintenance platform for cutting-edge mining services.
With a philosophy rooted in the origins of blockchain technology and cryptocurrency, Bitdeer Group is prepared to service customers who are in pursuit of stable, dependable crypto-financial growth.
About Bitdeer Group
Bitdeer Group is the world’s leading digital asset mining service provider. It was founded by Jihan Wu, a renowned pioneer in the crypto industry, along with Sequoia Capital, IDG, and other well-known investment institutions in the blockchain field.
Founded in 2023 with headquarters in Singapore, Bitdeer Group has branches in the United States, Europe, and other countries and regions. Under the group, there are currently three business lines — Bitdeer, Mining Datacenter, and smart mining service.
Together, they provide a full range of mining services, including mining machine sharing, mining infrastructure construction, and mining operation management.
For more information, please get in touch with Bitdeer Group:
GoPro HERO7 Black, Silver and White revealed: All the specs
GoPro, the action camera company that started it all, isn’t scheduled to unveil its latest generation of action cameras until later today, but someone seems to have been a wee bit too excited and pushed the “Publish” button a bit early. Thanks to that, we’re getting an early look at the GoPro HERO7 generation that has not just one, not even just two, but three cameras. Make no mistake, their difference goes beyond mere looks.
There are three HERO7 action cameras being launched this year: Black, Silver, and White. More than just aesthetic differences, the three cameras are color-coded for their specific capabilities, following the tradition GoPro has already set in their previous camera generations.
The HERO7 Black is the crème de la crème as far as features go. It’s the action camera for pros who want Hollywood-level footage. That’s no problem for the Black’s 4K 60 fps recording capabilities. That too much? You can also go lower at 2.7K for 120 fps. And if you really need super slow-mo, there’s 1080p at 240 fps too. And it isn’t just video either. The HERO7 Black records stereo and raw audio and can even support an external mic.
• Record 4K60, 2.7K120, and 1080p240 Video
• Capture 12MP Photos at up to 30 fps
• HyperSmooth Video Stabilization
• Vertical Portrait Mode for Social Media
• SuperPhoto Auto HDR Photo Enhancement
• 33′ Waterproof without a Housing
• Touch Zoom Framing via Intuitive 2″ LCD
• Face, Smile, and Scene Detection
• Live Streaming, TimeWarp Video
• Voice Control, Raw Photos, and Much More
Though not as capable, the HERO7 Silver doesn’t lag too far behind. It’s 10 megapixel sensor (versus the Black’s 12 MP) is still capable of 4K recording but capped at 30 fps. No super slow-mo either as its fastest frame rate stops at 60.
• Record 4K30, 1440p60, and 1080p60 Video
• Capture 10MP Photos at up to 15 fps
• Built-In Video Stabilization
• Vertical Portrait Mode for Social Media
• 33′ Waterproof without a Housing
• Touch Zoom Framing via Intuitive 2″ LCD
• Voice Control, Time-Lapse Capture
• Photo Timer for Individual/Group Selfies
• GPS Performance Stickers & More
A step lower is the HERO7 White, but don’t be quick to knock it for that. Its 10 megapixel sensor may only be capable of 1080p60 video but it shares many of the same qualities as Black and Silver. That includes built-in stabilization, a vertical capture mode that’s perfect for social media, a 2-inch touch screen, and, of course, a level of ruggedness that makes it impervious to water under 33 feet. And that’s without a waterproof case! In other words, while the Black is for the pros, the White is for the hobbyist who wants to get his feet wet. Literally even.
• Full HD 1080p60 Video
• 10MP Photos at up to 15 fps
• Built-In Video Stabilization
• Vertical Portrait Mode for Social Media
• 33′ Waterproof without a Housing
• Touch Zoom Framing via Intuitive 2″ LCD
• Voice Control, Time-Lapse Capture
• Photo Timer for Individual/Group Selfies
With a new range of HERO7 cameras for every kind of user, GoPro is set to recapture the action camera market that has been filling up with rivals and knockoffs. All that’s left now is to wait for GoPro to actually announce the HERO7 Black, HERO7 Silver, and HERO7 White and see how much they will cost.
The UA Band looks a lot like the Nike Fuelband but isn’t equipped with GPS.
The Health Box also contains a Bluetooth heart-rate chest strap and connected scale (creatively called UA Heart Rate and UA Scale) that will wirelessly send your vitals to the UA Record app. UA Record is the glue holding this mish mash of connected gear together.
But quite a few other fitness apps have been acquired by Under Armour – MapMyRun, MyFitnessPal and Endomondo – to further strengthen the bonds between these devices. For example, you can log your caloric intake with the UA Scale in MyFitnessPal and keep track of your training runs courtesy of MapMyRun. All of this standalone data is then collated in UA Record.
The best fitness apps to get into shape and stay there
But there’s more to UA’s connected health platform than just a wristband and scale. HTCand Under Armour also presented a couple of pairs of Bluetooth sports headphones at CES 2024: one with yet another heart-rate tracker (launching later this year) and another without. The more expensive set will sell for $250 and the base model will go for $180.
The UA Speedform Gemini 2 feature an embedded sensor to wirelessly track your runs.
But this diversification strategy goes even further. Under Armour also debuted their first pair of connected sneakers: the Speedform Gemini 2. These $150 sneakers have an embedded sensor that will track your run without the need for a fitness band, smartphone or any other connected wearable. The battery will supposedly outlast the shoes.
MediaTek is developing a wearable-centric chip
As you can probably tell, there’s a lot of redundancy in this product portfolio, with multiple devices tracking your heart rate or distance travelled, meaning there’s no real reason to own them all. This is perhaps why the sneakers and headphones didn’t make it into the Health Box, which incidentally, retails for $400 and will be available on January 22. You’ll also get premium app subscriptions with the Health Box.
The Under Armour Record app collates all of your fitness data in one place.
To buy the contents of the Health Box individually, you’ll need $180 for the UA Band or the UA Scale and $80 for the UA Heart Rate strap. While the products look great and Under Armour’s desire to get people more active is laudable, it’s uncertain how successful a move this will be for HTC, a company struggling with poor decision-making of late.
The strength of this new product portfolio is not likely to be the hardware itself. Nor will it necessarily be the idea of a connected health platform, because we can already synthesize all of our fitness data easily enough. No, it’s more likely to be the quality of the individual apps and the UA Record hub that is really going to make or break this idea.
Xiaomi takes third place in wearables market, Android Wear absent from top 5
HTC makes great hardware and Under Armour has a large enough huge user base to make this project viable. While none of these individual products are, realistically speaking, any better or worse than any others, the sheer variety of devices and the interconnected nature of the platform should give it the best chances of achieving its goal.
What do you think of the Health Box? Do you use wearables and apps to track your fitness?
Update the detailed information about Revealed: The World’s 10 Highest on the Bellydancehcm.com website. We hope the article's content will meet your needs, and we will regularly update the information to provide you with the fastest and most accurate information. Have a great day!